Sitemap

September 08, 2017 Articles

Filter by Available Specialty
  1. AAP updates pediatric hypertension guidelines to address rising prevalence
  2. Abbott to cease sales of bioresorbable vascular scaffold
  3. Abiraterone acetate offers no survival advantage over docetaxel for prostate cancer
  4. Abiraterone acetate plus prednisone improves health-related quality of life in metastatic prostate cancer
  5. Among injection drug users, young adults at highest risk for HCV
  6. Avycaz reduces risk for death from CRE by 23% compared with colistin
  7. Benzodiazepines, antidepressants do not affect cognition in schizophrenia
  8. Bevacizumab increases risk for adverse cardiac events
  9. Blepharoplasty recipients rated as appearing younger, more attractive
  10. Colon tissue more permeable to bacteria in IBS
  11. CooperVision removes Energys lens from UPP program
  12. Delphi exercise seen as a valuable tool in reaching expert consensus on large vessel vasculitis
  13. Don’t miss the latest news in contact lenses
  14. Early hearing interventions lead to better language outcomes
  15. Educational material may help reduce opioid consumption after hand surgery
  16. EPHESUS
  17. Ertugliflozin improves glycemic control, body weight, without adverse bone effects
  18. FDA claims EpiPen manufacturer ignored ‘hundreds’ of flaws
  19. FDA grants breakthrough therapy designation to cemiplimab for advanced cutaneous squamous cell carcinoma
  20. FDA rule banning 19 ingredients from antibacterial soaps takes effect
  21. Five ophthalmology clinical trial updates you might have missed
  22. Fracture risk assessment tool may be effective in nursing home setting
  23. Gender may influence how heavy drinking affects brain activity
  24. GISSI-3
  25. Glistening-free FineVision IOL gets CE approval
  26. Groups petition FDA to remove certain opioids from market
  27. High salt intake doubles risk for heart failure
  28. Hybrid minimally invasive esophagectomy reduces morbidity in esophageal cancer
  29. ICTUS Trial
  30. Injection drug users with HCV lack awareness of DAA efficacy
  31. International federation advocates for psoriasis at WHO meeting
  32. ISIS-1
  33. ISIS-2
  34. ISIS-3
  35. ISIS-4
  36. Long-term efficacy, safety seen with SB4 in patients with rheumatoid arthritis
  37. Maintenance rucaparib extends PFS in recurrent ovarian cancer
  38. Managing CV risk evolves with new research
  39. Mobility test tracks vision changes in inherited retinal dystrophies
  40. Nearly a quarter of women with small breast cancers at risk for distant metastases
  41. New drug effective, well tolerated in patients with osteoarthritis knee pain
  42. NORDISTEMI
  43. OASIS-5 Trial
  44. Obesity affects more than half of US adults
  45. Patients with TP53-mutated mantle cell lymphoma have ‘dismal’ outcomes
  46. Pembrolizumab may become standard for advanced gastric cancer
  47. PUBLICATION EXCLUSIVE: IRIS Registry offers many benefits for US ophthalmologists
  48. Red meat, poultry consumption increases type 2 diabetes risk
  49. Spinal Resources receives FDA 510(k) clearance for new pedicle screw system
  50. Study compares PROMIS instruments to other measures for carpal tunnel release
  51. T2 Biosystems collaborates with CDC, Cidara to combat Candida infections
  52. TIF controls chronic GERD symptoms through 4 years
  53. VIVA 17 to highlight integrated approaches to treat vascular disease
  54. WOSCOPS: Statins reduce mortality in men with very high LDL long term